Pomid 1mg, containing Pomalidomide, is a potent immunomodulatory drug manufactured by Pharma Lord. It is primarily used in the treatment of multiple myeloma, a type of cancer that forms in plasma cells. Pomalidomide is similar to thalidomide and lenalidomide, but it has been modified to improve its effectiveness and reduce side effects. This medication works by affecting the immune system, reducing inflammation, and stopping the growth of cancerous cells in the bone marrow.
Advantages:
- Effective in Relapsed or Refractory Multiple Myeloma: Pomid is often used in combination with other therapies for patients who have already tried two or more treatments (including lenalidomide and a proteasome inhibitor) without success.
- Immunomodulatory Action: Pomalidomide enhances immune system activity to help the body fight cancer cells more effectively.
- Anti-Cancer Properties: It inhibits the growth of myeloma cells and may also block the blood vessels that supply the tumor, helping to slow disease progression.
- Improved Survival: Clinical studies have shown that pomalidomide, in combination with other medications such as dexamethasone, can increase survival rates in patients with multiple myeloma who have relapsed or are resistant to prior treatments.
Uses:
- Treatment of relapsed or refractory multiple myeloma in patients who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor, and have shown disease progression on or within 60 days of completion of the last therapy.
- Enhances the body rsquo;s immune response to better control the growth and spread of cancer cells.
- Can be used in combination with other medications (e.g., dexamethasone) for a more effective treatment regimen.
Patients should be monitored closely for potential side effects, including low blood cell counts, and follow their healthcare provider's instructions carefully when using Pomid 1mg.